-
2
-
-
63449089608
-
Novel designs and end points for phase II clinical trials
-
Adjei A., Christian M., Ivy P. Novel designs and end points for phase II clinical trials. Clin Cancer Res 2009, 15(6):1866-1872.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.6
, pp. 1866-1872
-
-
Adjei, A.1
Christian, M.2
Ivy, P.3
-
3
-
-
51749123391
-
Speeding up the evaluation of new agents in cancer
-
Parmar M.K.B., Barthel F.M.S., Sydes M., Langley R., Kaplan R., Eisenhauer E., et al. Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst September 3 2008, 100(17):1204-1214.
-
(2008)
J Natl Cancer Inst
, vol.100
, Issue.17
, pp. 1204-1214
-
-
Parmar, M.K.B.1
Barthel, F.M.S.2
Sydes, M.3
Langley, R.4
Kaplan, R.5
Eisenhauer, E.6
-
4
-
-
15744381413
-
Randomized phase II trials: what does randomization gain?
-
Wieand H.S. Randomized phase II trials: what does randomization gain?. J Clin Oncol 2005, 23:1794-1795.
-
(2005)
J Clin Oncol
, vol.23
, pp. 1794-1795
-
-
Wieand, H.S.1
-
6
-
-
0000364767
-
New directions in adaptive designs
-
Rosenberger W.F. New directions in adaptive designs. Stat Sci 1996, 11(2):137-149.
-
(1996)
Stat Sci
, vol.11
, Issue.2
, pp. 137-149
-
-
Rosenberger, W.F.1
-
7
-
-
33947136401
-
Overhauling clinical trials
-
Scott C.T., Baker M. Overhauling clinical trials. Nat Biotechnol 2007, 25:287-292.
-
(2007)
Nat Biotechnol
, vol.25
, pp. 287-292
-
-
Scott, C.T.1
Baker, M.2
-
8
-
-
0034706254
-
Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial
-
Weijer C., Shapiro S.H., Glass K.C., Enkin M.W. Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. Br J Med 2000, 321:756-758.
-
(2000)
Br J Med
, vol.321
, pp. 756-758
-
-
Weijer, C.1
Shapiro, S.H.2
Glass, K.C.3
Enkin, M.W.4
-
10
-
-
23044510049
-
New paradigm in dose-finding trials: patient-specific dosing and beyond phase I
-
Rogatko A., Babb J.S., Tighiouart M., Khuri F.R., Hudes G. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I. Clin Cancer Res 2005, 11(15):5342-5346.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.15
, pp. 5342-5346
-
-
Rogatko, A.1
Babb, J.S.2
Tighiouart, M.3
Khuri, F.R.4
Hudes, G.5
-
11
-
-
36849035490
-
Translation of innovative designs into phase I trials
-
Rogatko A., Schoeneck D., Jonas W., Tighiouart M., Khuri F.R., Porter A. Translation of innovative designs into phase I trials. J Clin Oncol Nov 1 2007, 25(31):4982-4986.
-
(2007)
J Clin Oncol
, vol.25
, Issue.31
, pp. 4982-4986
-
-
Rogatko, A.1
Schoeneck, D.2
Jonas, W.3
Tighiouart, M.4
Khuri, F.R.5
Porter, A.6
-
12
-
-
84855356906
-
Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D. Health Care Report
-
Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D. Health Care Report. Business Insight; 2008.
-
(2008)
Business Insight.
-
-
-
13
-
-
39049179408
-
Searching for clinical evidence in citespace
-
Chaomei C., Yunan C. Searching for clinical evidence in citespace. AMIA Annu Symp Proc 2005, 2005:121-125.
-
(2005)
AMIA Annu Symp Proc
, vol.2005
, pp. 121-125
-
-
Chaomei, C.1
Yunan, C.2
-
14
-
-
58149163344
-
Statistical issues in translational cancer research
-
George S. Statistical issues in translational cancer research. Clin Cancer Res 2008, 14(19):5954-5958.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.19
, pp. 5954-5958
-
-
George, S.1
|